Search Results - "Tosta, Patti"

The immune cell landscape in kidneys of patients with lupus nephritis by Arazi, Arnon, Rao, Deepak A., Berthier, Celine C., Davidson, Anne, Liu, Yanyan, Hoover, Paul J., Chicoine, Adam, Eisenhaure, Thomas M., Jonsson, A. Helena, Li, Shuqiang, Lieb, David J., Zhang, Fan, Slowikowski, Kamil, Browne, Edward P., Noma, Akiko, Sutherby, Danielle, Steelman, Scott, Smilek, Dawn E., Tosta, Patti, Apruzzese, William, Massarotti, Elena, Dall’Era, Maria, Park, Meyeon, Kamen, Diane L., Furie, Richard A., Payan-Schober, Fernanda, Pendergraft, William F., McInnis, Elizabeth A., Buyon, Jill P., Petri, Michelle A., Putterman, Chaim, Kalunian, Kenneth C., Woodle, E. Steve, Lederer, James A., Hildeman, David A., Nusbaum, Chad, Raychaudhuri, Soumya, Kretzler, Matthias, Anolik, Jennifer H., Brenner, Michael B., Wofsy, David, Hacohen, Nir, Diamond, Betty

“…Lupus nephritis is a potentially fatal autoimmune disease for which the current treatment is ineffective and often toxic. To develop mechanistic hypotheses of…”
Get full text

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis by Atisha‐Fregoso, Yemil, Malkiel, Susan, Harris, Kristina M., Byron, Margie, Ding, Linna, Kanaparthi, Sai, Barry, William T., Gao, Wendy, Ryker, Kristin, Tosta, Patti, Askanase, Anca D., Boackle, Susan A., Chatham, W. Winn, Kamen, Diane L., Karp, David R., Kirou, Kyriakos A., Sam Lim, S., Marder, Bradley, McMahon, Maureen, Parikh, Samir V., Pendergraft, William F., Podoll, Amber S., Saxena, Amit, Wofsy, David, Diamond, Betty, Smilek, Dawn E., Aranow, Cynthia, Dall’Era, Maria

“…Objective To assess the safety, mechanism of action, and preliminary efficacy of rituximab followed by belimumab in the treatment of refractory lupus nephritis…”
Get full text

Treatment of Lupus Nephritis With Abatacept: The Abatacept and Cyclophosphamide Combination Efficacy and Safety Study by Askanase, Anca, Byron, Margie, Keyes-Elstein, Lynette, Cagnoli, Patricia, McCune, W. Joseph, Chatham, W. Winn, Contreras, Gabriel, Daikh, David, Dall'Era, Maria, Wofsy, David, Davidson, Anne, Diamond, Betty, Mackay, Meggan, Ding, Linna, Gao, Wendy, Dooley, Mary Anne, Fragoso-Loyo, Hilda, Sanchez-Guerrero, Jorge, Karp, David, Olsen, Nancy, Jolly, Meenakshi, Kalunian, Kenneth, Kamen, Diane, Lee, Iris, Levesque, Marc C., Lim, S. Sam, Ramos-Remus, Cesar, Rovin, Brad, Sayre, Peter, Smilek, Dawn, Tosta, Patti, Utset, Tammy, Venuturupalli, Swamy, Winchester, Robert

“…Objective To assess the efficacy and safety of a 24‐week course of abatacept in the treatment of active lupus nephritis and to assess the potential of…”
Get full text

Association of Autoantibody Concentrations and Trajectories With Lupus Nephritis Histologic Features and Treatment Response by Fava, Andrea, Wagner, Catriona A., Guthridge, Carla J., Kheir, Joseph, Macwana, Susan, DeJager, Wade, Gross, Tim, Izmirly, Peter, Belmont, H. Michael, Diamond, Betty, Davidson, Anne, Utz, Paul J., Weisman, Michael H, Magder, Laurence S., Lee, Chun‐Hao, Fine, Derek, Monroy‐Trujillo, Manny, Anolik, Jennifer, Shah, Ummara, Ishimori, Mariko, Clancy, Robert M., Belmont, Michael, Wu, Ming, Bornkamp, Nicole, Putterman, Chaim, Der, Evan, Goilav, Beatrice, Jordan, Nicole, Schwartz, Daniel, Pullman, James, Wofsy, David, Smilek, Dawn, Tosta, Patti, Kretzler, Matthias, Berthier, Celine C., Woodle, E. Steve, Hildeman, Dave, Brenner, Michael, Rao, Deepak, Guthridge, Joel M., Petri, Michelle, Buyon, Jill, James, Judith A.

“…Objective Autoantibodies are a hallmark of lupus nephritis (LN), but their association with LN classes and treatment response are not adequately known. In this…”
Get full text

ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis by Khoury, Samia J, Rochon, James, Ding, Linna, Byron, Margie, Ryker, Kristin, Tosta, Patti, Gao, Wendy, Freedman, Mark S, Arnold, Douglas L, Sayre, Peter H, Smilek, Dawn E

“…Background: Costimulatory blockade of T lymphocytes with the CTLA4-Ig fusion protein abatacept could be an effective treatment for the immune-mediated…”
Get full text

Publisher Correction: The immune cell landscape in kidneys of patients with lupus nephritis by Arazi, Arnon, Rao, Deepak A., Berthier, Celine C., Davidson, Anne, Liu, Yanyan, Hoover, Paul J., Chicoine, Adam, Eisenhaure, Thomas M., Jonsson, A. Helena, Li, Shuqiang, Lieb, David J., Zhang, Fan, Slowikowski, Kamil, Browne, Edward P., Noma, Akiko, Sutherby, Danielle, Steelman, Scott, Smilek, Dawn E., Tosta, Patti, Apruzzese, William, Massarotti, Elena, Dall’Era, Maria, Park, Meyeon, Kamen, Diane L., Furie, Richard A., Payan-Schober, Fernanda, Pendergraft, William F., McInnis, Elizabeth A., Buyon, Jill P., Petri, Michelle A., Putterman, Chaim, Kalunian, Kenneth C., Woodle, E. Steve, Lederer, James A., Hildeman, David A., Nusbaum, Chad, Raychaudhuri, Soumya, Kretzler, Matthias, Anolik, Jennifer H., Brenner, Michael B., Wofsy, David, Hacohen, Nir, Diamond, Betty

“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis by Georges, George E., Cohen, Jeffrey A, Griffith, Linda M., Steinmiller, Kati, Barry, Bill, Harris, Kristina, Ryker, Kristin, Rice, Janis, Tosta, Patti, McCarthy, Sean, Goldstein, Julia S, McNamara, James, Miller, Deborah, Carlson, Joshua J, Arnold, Douglas L, Smilek, Dawn E, Muraro, Paolo A.

“…Myeloablative and immunoablative therapy followed by autologous hematopoietic stem cell transplantation (AHSCT) has been shown to be effective in patients with…”
Get full text